Deconstructing the allo-specific memory B cell response
Deconstructing the allo-specific memory B cell response
批准号:
9210559
负责人:
Roger Sciammas
金额:
$18.62万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2018-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Deconstructing the allo-specific memory B cell response Allo-specific B cells and their antibody products are strongly predict with acute and chronic allograft rejection, especially in "sensitized" transplant recipients with pre-existing donr-specific antibodies (DSA). The source of antibody in the sensitized recipients derives from two distinct cellular pools: constitutive production of allo-specific antibody from the long lived plasa cell and de novo production from reactivated memory B cells in the recall response. While the long lived plasma cells can be viewed as a static population that produces a finite amount of antibody (life time times secretion rate), memory B cells represent a highly dynamic population that re- cycle indefinitely to produce bursts of antibody and to reseed the long lived plasma cell and memory B cell pools. Thus, we posit that understanding the roles of memory B cells under circumstances of transplantation, especially the mechanisms that regulate the dynamic behavior of allo-specific memory B cells, will ultimately prove to be important for controlling transplant rejection. Our work has uncovered a central regulator of B cell differentiation that controls the identity of differentiated B cells as a function of antigen affinity/avidity of the B cell antigen receptor (BCR). The Irf4 transcription factor controls the generation of plasma cells (PC) and Germinal Center B (GC B) cells by activating the expression of the rate limiting transcription factors important for those cell fates, Blimp-1 and Bcl6, respectively. We hypothesize that Irf4 plays a similarly critical role in controlling the generation of memory B cells as well as in controlling the dynamics of memory B cell reactivation. Furthermore, we have optimized a strategy to follow the fate of individual allogeneic MHC-specific B cells responding to transplants
in mice. This technology has enabled us to quantify the proportions of PC, GC B, and memory B cells after primary and secondary immunizations. Therefore we propose to define the life cycle of allo-antigen specific memory B cells and how that may be altered by costimulation blockade, to identify the conditions with which memory B cells reactivate, and to determine the impact of memory B cells on mechanisms of humoral rejection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
mRNA alternative polyadenylation in B cell development
-
批准号:10502155
-
项目类别:
-
资助金额:$79.4万
-
财政年份:2022
-
负责人:Roger Sciammas
-
依托单位:
mRNA alternative polyadenylation in B cell development
-
批准号:10880882
-
项目类别:
-
资助金额:$6.62万
-
财政年份:2022
-
负责人:Roger Sciammas
-
依托单位:
mRNA alternative polyadenylation in B cell development
-
批准号:10629377
-
项目类别:
-
资助金额:$77.68万
-
财政年份:2022
-
负责人:Roger Sciammas
-
依托单位:
Heterogeneity of plasma cell states is regulated by the dynamics of IRF4 expression
-
批准号:10092104
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2020
-
负责人:Roger Sciammas
-
依托单位:
Deconstructing the allo-specific memory B cell response
-
批准号:9104091
-
项目类别:
-
资助金额:$39.34万
-
财政年份:2014
-
负责人:Roger Sciammas
-
依托单位:
Role of IRF4 in T helper cell fate decisions
-
批准号:8836931
-
项目类别:
-
资助金额:$38.8万
-
财政年份:2014
-
负责人:Roger Sciammas
-
依托单位:
Deconstructing the allo-specific memory B cell response
-
批准号:8671244
-
项目类别:
-
资助金额:$41.17万
-
财政年份:2014
-
负责人:Roger Sciammas
-
依托单位:
Role of IRF4 in T helper cell fate decisions
-
批准号:9205296
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2014
-
负责人:Roger Sciammas
-
依托单位:
Deconstructing the allo-specific memory B cell response
-
批准号:9318112
-
项目类别:
-
资助金额:$39.1万
-
财政年份:2014
-
负责人:Roger Sciammas
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Allo-HSCT后靶向递送IL-15/IL-15Rα上调AML细胞MHC表达分离GVL与GVHD的实验研究
-
批准号:82370220
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:石威
-
依托单位:
芳烃受体AHR调节allo-HSCT后胸腺重建的机制研究
-
批准号:82370218
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:潘彬
-
依托单位:
巨细胞病毒再激活通过IFN-γ--HLA途径降低ALLO-HSCT后AML复发的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:王昱
-
依托单位:
从DLI探索靶向干预VLA-4促进Allo-HSCT后HSC植入的作用及机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:宋献民
-
依托单位:
基于TCR分析的allo-HSCT后早期T细胞免疫重建与aGVHD发生的机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:赵鹏
-
依托单位:
羊膜间充质干细胞来源的EVs通过抑制NLRP3炎性小体激活改善allo-HSCT后aGVHD的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:高雅
-
依托单位:
ADAM10调控小鼠allo-HSCT后GVHD和GVL的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:陈翀
-
依托单位:
通过活化LILRB4受体诱导allo-T细胞的免疫耐受研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:邹义洲
-
依托单位:
骨髓血管内皮细胞HIF-1α低表达介导的自噬受损在allo-HSCT后aGVHD中的作用及机制研究
-
批准号:82100233
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:曹谢娜
-
依托单位:
巨细胞病毒再激活通过阻止T细胞功能耗竭降低Allo-HSCT后AML复发的机制研究
-
批准号:82070189
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:王昱
-
依托单位: